Bisphosphonate treatment (oral or intravenous) vs placebo or no treatment
Number of participants reporting an adverse event · children under the age of 18 with cerebral palsy (GMFCS levels III to V)
1 finding from 1 review
- no estimate extracted1 study · 12 participantsGRADE not reported